Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach.
Fitzpatrick JM, Anderson J, Sternberg CN, Fleshner N, Fizazi K, Rébillard X, Dogliotti L, Conti G, Turesson I, James N, Heidenreich A, Solsona E, Guillem V, Herchenhorn D, Moul J, van Moorselaar J, Coetzee LJ, Wilson A, Bamias A, De Wit R, Chrisofos M. Fitzpatrick JM, et al. Among authors: chrisofos m. Crit Rev Oncol Hematol. 2008 Oct;68 Suppl 1:S9-S22. doi: 10.1016/j.critrevonc.2008.07.019. Epub 2008 Aug 23. Crit Rev Oncol Hematol. 2008. PMID: 18723368 Review.
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer.
Mountzios I, Bournakis E, Efstathiou E, Varkaris A, Wen S, Chrisofos M, Deliveliotis C, Alamanis C, Anastasiou I, Constantinides C, Karadimou A, Tsiatas M, Papadimitriou C, Bamias A, Dimopoulos MA. Mountzios I, et al. Among authors: chrisofos m. Urology. 2011 Mar;77(3):682-7. doi: 10.1016/j.urology.2010.08.044. Epub 2011 Jan 22. Urology. 2011. PMID: 21256546
Referral for "Neoadjuvant Chemotherapy" for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes.
Dellis A, Zakopoulou R, Kougioumtzopoulou A, Tzannis K, Koutsoukos K, Fragkoulis C, Kostouros E, Papatsoris A, Varkarakis I, Stravodimos K, Boutati E, Pagoni S, Seferlis M, Chrisofos M, Kouloulias V, Ntoumas K, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamias A. Dellis A, et al. Among authors: chrisofos m. Cancer Manag Res. 2021 Jul 30;13:5941-5955. doi: 10.2147/CMAR.S317500. eCollection 2021. Cancer Manag Res. 2021. PMID: 34354376 Free PMC article.
The novel prostate cancer antigen 3 (PCA3) biomarker.
Bourdoumis A, Papatsoris AG, Chrisofos M, Efstathiou E, Skolarikos A, Deliveliotis C. Bourdoumis A, et al. Among authors: chrisofos m. Int Braz J Urol. 2010 Nov-Dec;36(6):665-8; discussion 669. doi: 10.1590/s1677-55382010000600003. Int Braz J Urol. 2010. PMID: 21176272 Free article. Review.
69 results